Lamifer-XT Tablet is a combination pharmaceutical formulation containing Ferrous Ascorbate (100 mg), Folic Acid (1.5 mg), and Zinc (22.5 mg), designed to address and prevent nutritional deficiencies commonly associated with anemia and impaired hematopoiesis. Ferrous Ascorbate serves as a bioavailable source of elemental iron, essential for hemoglobin synthesis and effective oxygen transport in the bloodstream. Folic Acid, a vital B-vitamin, plays a crucial role in DNA synthesis and red blood cell maturation, thereby supporting the prevention of megaloblastic anemia. Zinc, an essential trace element, contributes to immune function, enzymatic reactions, and cellular metabolism, enhancing overall hematologic health. Lamifer-XT is indicated for the treatment and prophylaxis of iron deficiency anemia, particularly in populations with increased iron requirements such as pregnant and lactating women, adolescents, and individuals with chronic blood loss. The combination ensures improved absorption and utilization of iron, while concurrently addressing folate and zinc deficiencies that may exacerbate anemic conditions. Administration should be as per physician guidance, with caution advised in patients with hemochromatosis or hypersensitivity to any component. Regular monitoring of hematologic parameters is recommended to assess therapeutic response and avoid potential adverse effects such as gastrointestinal discomfort or zinc-induced copper deficiency.